HOME >> BIOLOGY >> NEWS
WSU scientist part of study seeking vaccines to combat potential bioterrorist attack

A research scientist at Wright State University is involved in a $1 million federal grant to combat a terrorist attack involving biological weapons.

Dawn Wooley, Ph.D., an associate professor in anatomy and physiology, is part of the Midwest Center of Excellence for Biodefense and Emerging Infectious Diseases Research.

"Our goal is to develop the diagnostic tools, therapeutics and vaccines that can be used to combat lethal agents or viruses and other infectious diseases identified by the Centers for Disease Control. We are particularly interested in agents that can be spread through the air," explained Wooley, who holds a doctorate from Harvard Medical School in virology, which is the study of viruses and viral diseases.

She became interested in this project after the terrorist attacks on Sept. 11, 2001, and subsequent anthrax scare. "My principal research work involves AIDS, but the threat involving bioterrorism is so great that I could not resist getting involved. This is so important to the United States and the world because some of these agents can kill people within a few days. Just think back to what the anthrax scare did to the postal service and you can realize how frightening a situation this can be."

The Midwest Center is a group of eight universities, including Wright State, which received funding from the National Institutes of Health. The University of Minnesota is the principal investigator and The Ohio State University is the co-principal investigator. The WSU research scientist is working with colleagues at both universities in her phase of the two-year project.

Wooley, who received initial funding for this project from Wright State, said the other participating institutions are the University of Cincinnati; University of Michigan; Indiana University; University of Illinois, Chicago; and Northwestern University.

The planning grant funds from NIH are related to a recently announced award of $350 mil
'"/>

Contact: Dawn Wooley
dawn.wooley@wright.edu
937-775-4993
Wright State University
15-Oct-2003


Page: 1 2

Related biology news :

1. EMBO Gold Medal 2004 goes to Spanish scientist
2. DNA lends scientists a hand, revealing new chemical reactions
3. UCSF scientist Joe Derisi named MaCarthur Fellow
4. Conference at UH opens doors for new scientists, engineers
5. Wisconsin scientists develop quick botox test
6. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
7. Alaska scientists find Arctic tundra yields surprising carbon loss
8. DuPont scientist named one of the worlds top young innovators by MITs Technology Review Magazine
9. UAF scientists discover new marine habitat in Alaska
10. Information system to help scientists analyze mechanisms of social behavior
11. White House to honor UNC School of Medicine scientist for early career achievement

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... and HAMILTON, Bermuda , Feb. ... ADXS ) and SELLAS Life ... on developing cancer immunotherapies, today announced that Advaxis ... novel cancer immunotherapy agent using Advaxis, proprietary ... WT1 targeted heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change ... advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. ...
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
Breaking Biology Technology:
Cached News: